Literature DB >> 1162981

Migraine.

N H Raskin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1162981      PMCID: PMC1130380     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


× No keyword cloud information.
  10 in total

1.  MONOAMINE OXIDASE INHIBITORS, TYRAMINE, AND CHESSE.

Authors:  D HORWITZ; W LOVENBERG; K ENGELMAN; A SJOERDSMA
Journal:  JAMA       Date:  1964-06-29       Impact factor: 56.272

2.  On migraine headache: serotonin and serotonin antagonism.

Authors:  D J DALESSIO
Journal:  JAMA       Date:  1962-07-28       Impact factor: 56.272

3.  Evaluation of clonidine in prophylaxis of migraine. Double-blind trial and follow-up.

Authors:  J Shafar; E R Tallett; P A Knowlson
Journal:  Lancet       Date:  1972-02-19       Impact factor: 79.321

4.  A phenylethylamine oxidising defect in migraine.

Authors:  M Sandler; M B Youdim; E Hanington
Journal:  Nature       Date:  1974-07-26       Impact factor: 49.962

5.  Effect of reserpine injections in migrainous and normal control subjects, with estimations of urinary 5-hydroxyindoleacetic acid.

Authors:  R N Tandon; B K Sur; K Nath
Journal:  Neurology       Date:  1969-11       Impact factor: 9.910

6.  Plasma serotonin in migraine and stress.

Authors:  M Anthony; H Hinterberger; J W Lance
Journal:  Arch Neurol       Date:  1967-05

7.  Migrainous neuralgia or cluster headache?

Authors:  J W Lance; M Anthony
Journal:  J Neurol Sci       Date:  1971-08       Impact factor: 3.181

8.  Cheese reaction and tyramine.

Authors:  K Price; S E Smith
Journal:  Lancet       Date:  1971-01-16       Impact factor: 79.321

9.  Amitriptyline in migraine prophylaxis. Changes in pattern of attacks during a controlled clinical trial.

Authors:  J D Gomersall; A Stuart
Journal:  J Neurol Neurosurg Psychiatry       Date:  1973-08       Impact factor: 10.154

10.  Propranolol in the treatment of migraine.

Authors:  T E Wideroe; T Vigander
Journal:  Br Med J       Date:  1974-06-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.